Optimizing use of multi-antibody assays for Lyme disease diagnosis: A bioinformatic approach.
Multiple different recombinant and peptide antigens are now available for serodiagnosis of Lyme disease (LD), but optimizing test utilization remains challenging. Since 1995 the Centers for Disease Control and Prevention (CDC) has recommended a 2-tiered serologic approach consisting of a first-tier...
Enregistré dans:
Auteurs principaux: | , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Public Library of Science (PLoS)
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/75ac4a0f062f493f9a23a39e4c34413c |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|